当前位置：
X-MOL 学术
›
N. Engl. J. Med.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Fazirsiran for Liver Disease Associated with Alpha1-Antitrypsin Deficiency
The New England Journal of Medicine ( IF 96.2 ) Pub Date : 2022-06-25 , DOI: 10.1056/nejmoa2205416 Pavel Strnad 1 , Mattias Mandorfer 1 , Gourab Choudhury 1 , William Griffiths 1 , Christian Trautwein 1 , Rohit Loomba 1 , Thomas Schluep 1 , Ting Chang 1 , Min Yi 1 , Bruce D Given 1 , James C Hamilton 1 , Javier San Martin 1 , Jeffery H Teckman 1
The New England Journal of Medicine ( IF 96.2 ) Pub Date : 2022-06-25 , DOI: 10.1056/nejmoa2205416 Pavel Strnad 1 , Mattias Mandorfer 1 , Gourab Choudhury 1 , William Griffiths 1 , Christian Trautwein 1 , Rohit Loomba 1 , Thomas Schluep 1 , Ting Chang 1 , Min Yi 1 , Bruce D Given 1 , James C Hamilton 1 , Javier San Martin 1 , Jeffery H Teckman 1
Affiliation
New England Journal of Medicine, Ahead of Print.
中文翻译：
Fazirsiran 治疗与 Alpha1-抗胰蛋白酶缺乏相关的肝病
新英格兰医学杂志，印刷前。
更新日期：2022-06-27
中文翻译：
Fazirsiran 治疗与 Alpha1-抗胰蛋白酶缺乏相关的肝病
新英格兰医学杂志，印刷前。
京公网安备 11010802027423号